{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:33:49Z","timestamp":1794382429526,"version":"4.9.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","award":["19-03-00043"],"award-info":[{"award-number":["19-03-00043"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.neuropharm.2020.108236","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T02:36:24Z","timestamp":1595471784000},"page":"108236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Slow-binding inhibitors of acetylcholinesterase of medical interest"],"prefix":"10.1016","volume":"177","author":[{"given":"Sofya V.","family":"Lushchekina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Masson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108236_bib1","doi-asserted-by":"crossref","first-page":"13220","DOI":"10.1073\/pnas.0605370103","article-title":"Effective countermeasure against poisoning by organophosphorus insecticides and nerve agents","volume":"103","author":"Albuquerque","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108236_bib2","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1021\/bi00447a029","article-title":"Inhibition kinetics of acetylcholinesterase with fluoromethyl ketones","volume":"28","author":"Allen","year":"1989","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2020.108236_bib3","doi-asserted-by":"crossref","first-page":"5514","DOI":"10.1073\/pnas.1523362113","article-title":"Structure of a prereaction complex between the nerve agent sarin, its biological target acetylcholinesterase, and the antidote HI-6","volume":"113","author":"Allgardsson","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2020.108236_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.bcp.2013.01.016","article-title":"Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity","volume":"85","author":"Artursson","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0026-895X(25)10030-8","article-title":"Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase","volume":"45","author":"Ashani","year":"1994","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/0006-291X(92)90649-6","article-title":"Mechanism of inhibition of cholinesterases by huperzine A","volume":"184","author":"Ashani","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuropharm.2020.108236_bib7","series-title":"Kinetics of Enzyme-Modifier Interactions. Springer","author":"Baici","year":"2015"},{"key":"10.1016\/j.neuropharm.2020.108236_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/cbdv.200800334","article-title":"3-Fluoro-2,4-dioxa-3-phosphadecalins as inhibitors of acetylcholinesterase. A reappraisal of kinetic mechanisms and diagnostic methods","volume":"6","author":"Baici","year":"2009","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.neuropharm.2020.108236_bib9","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1021\/bi020016x","article-title":"Kinetic and structural studies on the interaction of cholinesterases with the anti-Alzheimer drug rivastigmine","volume":"41","author":"Bar-On","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2020.108236_bib10","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1021\/jm901296p","article-title":"Probing Torpedo californica acetylcholinesterase catalytic gorge with two novel bis-functional galanthamine derivatives","volume":"53","author":"Bartolucci","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib11","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/1097-0134(20010201)42:2<182::AID-PROT50>3.0.CO;2-1","article-title":"Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs","volume":"42","author":"Bartolucci","year":"2001","journal-title":"Protein Struct. Funct. Genet."},{"key":"10.1016\/j.neuropharm.2020.108236_bib12","series-title":"Reversible Ligand Binding: Theory and Experiment","author":"Bellelli","year":"2017"},{"key":"10.1016\/j.neuropharm.2020.108236_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neuropharm.2020.108236_bib14","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1073\/pnas.0308206100","article-title":"Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation","volume":"101","author":"Bourne","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2020.108236_bib15","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2018.00112","article-title":"Treating cocaine addiction, obesity, and emotional disorders by viral gene transfer of butyrylcholinesterase","volume":"9","author":"Brimijoin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0005-2744(79)90122-0","article-title":"Fluorinated aldehydes and ketones acting as quasi-substrate inhibitors of acetylcholinesterase","volume":"567","author":"Brodbeck","year":"1979","journal-title":"Biochim. Biophys. Acta Enzymol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1080\/14756366.2018.1458030","article-title":"Kinetic and structural studies on the interactions of Torpedo californica acetylcholinesterase with two donepezil-like rigid analogues","volume":"33","author":"Caliandro","year":"2018","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib18","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1021\/jm000980y","article-title":"New tacrine-huperzine A hybrids (huprines): highly potent tight-binding acetylcholinesterase inhibitors of interest for the treatment of Alzheimer's disease","volume":"43","author":"Camps","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1021\/tx3004505","article-title":"Inhibition pathways of the potent organophosphate CBDP with cholinesterases revealed by X-ray crystallographic snapshots and mass spectrometry","volume":"26","author":"Carletti","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1021\/tx100447k","article-title":"Reaction of cresyl saligenin phosphate, the organophosphorus implicated in the aerotoxic syndrome, with human cholinesterases: mechanistic studies employing kinetics, mass spectrometry and x-ray structure analysis","volume":"24","author":"Carletti","year":"2011","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib21","series-title":"Vitamin E and Alzheimer's Disease-Is it Time for Personalized Medicine?","author":"Cervantes","year":"2017"},{"key":"10.1016\/j.neuropharm.2020.108236_bib22","doi-asserted-by":"crossref","first-page":"108715","DOI":"10.1016\/j.cbi.2019.06.028","article-title":"Molecular dynamics simulations of the interaction of Mouse and Torpedo acetylcholinesterase with covalent inhibitors explain their differential reactivity: implications for drug design","volume":"310","author":"Chandar","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2020.108236_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0167-4838(94)90067-1","article-title":"Inhibition of cholinesterase activity by tetrahydroaminoacridine and the hemisuccinate esters of tocopherol and cholesterol","volume":"1206","author":"Chelliah","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2020.108236_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.str.2017.11.021","article-title":"Structure of the G119S mutant acetylcholinesterase of the malaria vector Anopheles gambiae reveals basis of insecticide resistance","volume":"26","author":"Cheung","year":"2018","journal-title":"Structure"},{"key":"10.1016\/j.neuropharm.2020.108236_bib25","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cbi.2008.05.023","article-title":"[+]-Huperzine A treatment protects against N-methyl-D-aspartate-induced seizure\/status epilepticus in rats","volume":"175","author":"Coleman","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2020.108236_bib27","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1107\/S0907444907044472","article-title":"Use of a 'caged' analogue to study the traffic of choline within acetylcholinesterase by kinetic crystallography","volume":"63","author":"Colletier","year":"2007","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"10.1016\/j.neuropharm.2020.108236_bib28","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1517\/17460441003677725","article-title":"The dynamics of drug-target interactions: drug-target residence time and its impact on efficacy and safety","volume":"5","author":"Copeland","year":"2010","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2020.108236_bib29","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4155\/fmc.11.112","article-title":"Conformational adaptation in drug-target interactions and residence time","volume":"3","author":"Copeland","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib30","series-title":"Evaluation of Enzyme Inhibitors in Drug Discovery: a Guide for Medicinal Chemists and Pharmacologists","author":"Copeland","year":"2013"},{"key":"10.1016\/j.neuropharm.2020.108236_bib31","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0009-9236(95)90072-1","article-title":"Acetylcholinesterase inhibition by zifrosilone: pharmacokinetics and pharmacodynamics*","volume":"58","author":"Cutler","year":"1995","journal-title":"Clin. Pharmacol. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108236_bib32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/14756366.2016.1220377","article-title":"New N,N-dimethylcarbamate inhibitors of acetylcholinesterase: design synthesis and biological evaluation","volume":"31","author":"De Vita","year":"2016","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib33","first-page":"1245","article-title":"Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery","volume":"45","author":"Dow","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.neuropharm.2020.108236_bib34","doi-asserted-by":"crossref","first-page":"10810","DOI":"10.1021\/bi020151+","article-title":"X-ray structures of Torpedo californica acetylcholinesterase complexed with (+)-huperzine A and (-)-huperzine B: structural evidence for an active site rearrangement","volume":"41","author":"Dvir","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2020.108236_bib35","first-page":"19694","article-title":"Fasciculin 2 binds to the peripheral site on acetylcholinesterase and inhibits substrate hydrolysis by slowing a step involving proton transfer during enzyme acylation","volume":"270","author":"Eastman","year":"1995"},{"key":"10.1016\/j.neuropharm.2020.108236_bib36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jpba.2018.03.060","article-title":"Combination of human acetylcholinesterase and serum albumin sensing surfaces as highly informative analytical tool for inhibitor screening","volume":"155","author":"Fabini","year":"2018","journal-title":"J. Pharmaceut. Biomed. Anal."},{"key":"10.1016\/j.neuropharm.2020.108236_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ncl.2018.01.011","article-title":"Treatment of myasthenia gravis","volume":"36","author":"Farmakidis","year":"2018","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.neuropharm.2020.108236_bib38","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev.bi.48.070179.002351","article-title":"Slow transitions and hysteretic behavior in enzymes","volume":"48","author":"Frieden","year":"1979","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0303-2647(99)00053-2","article-title":"Kinetic analysis of enzyme reactions with slow-binding inhibition","volume":"51","author":"Garrido-del Solo","year":"1999","journal-title":"Biosystems"},{"key":"10.1016\/j.neuropharm.2020.108236_bib40","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/0005-2744(76)90260-6","article-title":"Differences in subunit activities in acetylcholinesterase as possible cause for apparent deviation from normal Michaelis-Menten kinetics","volume":"438","author":"Gebtinetta","year":"1976","journal-title":"Biochim. Biophys. Acta Enzymol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib41","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1039\/C9CP02613D","article-title":"Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study","volume":"21","author":"Ghosh","year":"2019","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.neuropharm.2020.108236_bib42","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bpc.2014.03.003","article-title":"Distinguishing induced fit from conformational selection","volume":"189","author":"Gianni","year":"2014","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib43","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1021\/bi001024l","article-title":"Interaction of Drosophila acetylcholinesterases with D-tubocurarine: an explanation of the activation by an inhibitor","volume":"40","author":"Golicnik","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2020.108236_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0167-4838(02)00285-6","article-title":"Multi-step analysis as a tool for kinetic parameter estimation and mechanism discrimination in the reaction between tight-binding fasciculin 2 and electric eel acetylcholinesterase","volume":"1597","author":"Goli\u010dnik","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2020.108236_bib45","doi-asserted-by":"crossref","first-page":"15405","DOI":"10.1021\/ja0466154","article-title":"The complex of a bivalent derivative of galanthamine with torpedo acetylcholinesterase displays drastic deformation of the active-site gorge: implications for structure-based drug design","volume":"126","author":"Greenblatt","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2020.108236_bib46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0014-5793(99)01637-3","article-title":"Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution","volume":"463","author":"Greenblatt","year":"1999","journal-title":"FEBS (Fed. Eur. Biochem. Soc.) Lett."},{"key":"10.1016\/j.neuropharm.2020.108236_bib47","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/0024-3205(94)00501-X","article-title":"Huperzine A as a pretreatment candidate drug against nerve agent toxicity","volume":"54","author":"Grunwald","year":"1994","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122504","article-title":"Role of vitamin E in the treatment of Alzheimer's disease: evidence from animal models","volume":"18","author":"Gugliandolo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib49","doi-asserted-by":"crossref","DOI":"10.1021\/ct400273t","article-title":"Efficient determination of protein-protein standard binding free energies from first principles","volume":"9","author":"Gumbart","year":"2013","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.neuropharm.2020.108236_bib50","series-title":"Handbook of Toxicology of Chemical Warfare Agents","year":"2020"},{"key":"10.1016\/j.neuropharm.2020.108236_bib51","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2020.108236_bib52","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1021\/ja952232h","article-title":"The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase","volume":"118","author":"Harel","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2020.108236_bib53","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.taap.2006.12.023","article-title":"The combination of donepezil and procyclidine protects against soman-induced seizures in rats","volume":"220","author":"Haug","year":"2007","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1580\/1080-6032(1996)007[0133:BATOTM]2.3.CO;2","article-title":"Biology and treatment of the mamba snakebite","volume":"7","author":"Hodgson","year":"1996","journal-title":"Wilderness Environ. Med."},{"key":"10.1016\/j.neuropharm.2020.108236_bib55","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bcp.2009.08.027","article-title":"Crystal structures of oxime-bound fenamiphos-acetylcholinesterases: reactivation involving flipping of the His447 ring to form a reactive Glu334-His447-oxime triad","volume":"79","author":"Hornberg","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib56","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1042\/bst0220758","article-title":"Trimethylsilylated trifluoromethyl ketones, a novel class of acetylcholinesterase inhibitors: biochemical and pharmacological profile of MDL 73,745","volume":"22","author":"Hornsperger","year":"1994","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.neuropharm.2020.108236_bib57","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1021\/bi00833a018","article-title":"Effect of charge on the carbamylation and binding constants of eel acetylcholinesterase in reaction with neostigmine and related carbamates","volume":"8","author":"Iverson","year":"1969","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2020.108236_bib58","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.pbb.2005.06.017","article-title":"Anticholinesterase (DFP) toxicity antagonism by chronic donepezil: a potential nerve agent treatment","volume":"81","author":"Janowsky","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108236_bib59","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1016\/j.bmc.2016.08.048","article-title":"Development of acetophenone ligands as potential neuroimaging agents for cholinesterases","volume":"24","author":"Jollymore-Hughes","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib60","first-page":"232","article-title":"Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroaspis angusticeps","volume":"79","author":"Karlsson","year":"1984","journal-title":"J. Physiol. (Paris)"},{"key":"10.1016\/j.neuropharm.2020.108236_bib61","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1042\/BCJ20160084","article-title":"Slow-binding inhibition of acetylcholinesterase by an alkylammonium derivative of 6-methyluracil: mechanism and possible advantages for myasthenia gravis treatment","volume":"473","author":"Kharlamova","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2020.108236_bib62","doi-asserted-by":"crossref","first-page":"6686","DOI":"10.1021\/ja043031t","article-title":"In situ selection of lead compounds by click chemistry: target-guided optimization of acetylcholinesterase inhibitors","volume":"127","author":"Krasinski","year":"2005","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2020.108236_bib63","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0969-2126(99)80040-9","article-title":"Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs","volume":"7","author":"Kryger","year":"1999","journal-title":"Structure"},{"key":"10.1016\/j.neuropharm.2020.108236_bib64","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/1521-3757(20020315)114:6<1095::AID-ANGE1095>3.0.CO;2-3","article-title":"Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks","volume":"114","author":"Lewis","year":"2002","journal-title":"Angew. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib65","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/febs.14747","article-title":"Molecular insights into the mechanism of 4-hydroxyphenylpyruvate dioxygenase inhibition: enzyme kinetics, X-ray crystallography and computational simulations","volume":"286","author":"Lin","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.neuropharm.2020.108236_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20040879","article-title":"The effectiveness of vitamin E treatment in Alzheimer's disease","volume":"20","author":"Lloret","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib67","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/cbic.200300571","article-title":"Photoreversible inhibition of cholinesterases: catalytic serine-labeled caged butyrylcholinesterase","volume":"4","author":"Loudwig","year":"2003","journal-title":"Chembiochem"},{"key":"10.1016\/j.neuropharm.2020.108236_bib68","first-page":"89","article-title":"Supercomputer modeling of dual-site acetylcholinesterase (AChE) inhibition","volume":"5","author":"Lushchekina","year":"2018","journal-title":"Supercomput. Front. Innovat."},{"key":"10.1016\/j.neuropharm.2020.108236_bib69","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12031-013-0178-2","article-title":"Molecular modeling evidence for His438 flip in the mechanism of butyrylcholinesterase hysteretic behavior","volume":"52","author":"Lushchekina","year":"2014","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib70","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1007\/s11172-013-0366-9","article-title":"Molecular modeling of butyrylcholinesterase inhibition by cresyl saligenin phosphate","volume":"62","author":"Lushchekina","year":"2013","journal-title":"Russ. Chem. Bull."},{"key":"10.1016\/j.neuropharm.2020.108236_bib71","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0021-9258(18)91862-4","article-title":"Kinetic evidence of multiple reversible cholinesterases based on inhibition by organophosphates","volume":"244","author":"Main","year":"1969","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib72","doi-asserted-by":"crossref","first-page":"103097","DOI":"10.1016\/j.bioorg.2019.103097","article-title":"Synthesis, molecular docking, and biological evaluation of 3-oxo-2-tolylhydrazinylidene-4,4,4-trifluorobutanoates bearing higher and natural alcohol moieties as new selective carboxylesterase inhibitors","volume":"91","author":"Makhaeva","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib73","doi-asserted-by":"crossref","first-page":"12809","DOI":"10.1021\/ja046382g","article-title":"In situ click chemistry: enzyme inhibitors made to their own specifications","volume":"126","author":"Manetsch","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2020.108236_bib74","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1007\/s00204-017-1946-5","article-title":"Phenyl valerate esterase activity of human butyrylcholinesterase","volume":"91","author":"Mangas","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib75","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1134\/S0006297912100070","article-title":"Time-dependent kinetic complexities in cholinesterase-catalyzed reactions","volume":"77","author":"Masson","year":"2012","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.neuropharm.2020.108236_bib76","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1042\/BJ20130389","article-title":"Effects of viscosity and osmotic stress on the reaction of human butyrylcholinesterase with cresyl saligenin phosphate, a toxicant related to aerotoxic syndrome: kinetic and molecular dynamics studies","volume":"454","author":"Masson","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2020.108236_bib77","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.abb.2016.02.010","article-title":"Slow-binding inhibition of cholinesterases, pharmacological and toxicological relevance","volume":"593","author":"Masson","year":"2016","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.neuropharm.2020.108236_bib78","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0306-4522(01)00613-3","article-title":"Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine","volume":"110","author":"Mesulam","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108236_bib79","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1134\/S1819712419010161","article-title":"The effect of alpha-tocopherol on the activity of acetylcholinesterases from different sources","volume":"13","author":"Molochkina","year":"2019","journal-title":"Neurochem. J."},{"key":"10.1016\/j.neuropharm.2020.108236_bib80","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/0968-0004(82)90157-8","article-title":"The slow-binding and slow, tight-binding inhibition of enzyme-catalysed reactions","volume":"7","author":"Morrison","year":"1982","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib81","first-page":"347","article-title":"Approaches to the study and analysis of the inhibition of enzymes by slow- and tight-binding inhibitors","volume":"2","author":"Morrison","year":"1985","journal-title":"Comments Mol. Cell. Biophys."},{"key":"10.1016\/j.neuropharm.2020.108236_bib82","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21103438","article-title":"Improving anti-neurodegenerative benefits of acetylcholinesterase inhibitors in Alzheimer's disease: are irreversible inhibitors the future?","volume":"21","author":"Moss","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib83","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1570159X11311040004","article-title":"Natural AChE inhibitors from plants and their contribution to Alzheimer's disease therapy","volume":"11","author":"Murray","year":"2013","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pbb.2009.10.011","article-title":"Systemic administration of the potential countermeasure huperzine reversibly inhibits central and peripheral acetylcholinesterase activity without adverse cognitive-behavioral effects","volume":"94","author":"Myers","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108236_bib85","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.neubiorev.2016.10.017","article-title":"Pretreatment and prophylaxis against nerve agent poisoning: are undesirable behavioral side effects unavoidable?","volume":"71","author":"Myhrer","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2020.108236_bib86","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.pbb.2010.02.010","article-title":"Behavioral side effects in rats treated with acetylcholinesterase inhibitors suggested used as prophylactics against nerve agents","volume":"95","author":"Myhrer","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108236_bib87","doi-asserted-by":"crossref","first-page":"9939","DOI":"10.1021\/ja00075a009","article-title":"m-(N, N,N-Trimethylammonio)trifluoroacetophenone: a femtomolar inhibitor of acetylcholinesterase","volume":"115","author":"Nair","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2020.108236_bib88","doi-asserted-by":"crossref","first-page":"8566","DOI":"10.1021\/bi00194a023","article-title":"Molecular recognition in acetylcholinesterase catalysis: free-energy correlations for substrate turnover and inhibition by trifluoro ketone transition-state analogs","volume":"33","author":"Nair","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2020.108236_bib89","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1070\/RC2012v081n11ABEH004311","article-title":"Quantum chemical modelling in the research of molecular mechanisms of enzymatic catalysis","volume":"81","author":"Nemukhin","year":"2012","journal-title":"Russ. Chem. Rev."},{"key":"10.1016\/j.neuropharm.2020.108236_bib90","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuint.2015.07.018","article-title":"Plant alkaloids as drug leads for Alzheimer's disease","volume":"89","author":"Ng","year":"2015","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2020.108236_bib91","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1021\/acs.jpcb.6b04089","article-title":"Serine protease catalysis: a computational study of tetrahedral intermediates and inhibitory adducts","volume":"120","author":"Ngo","year":"2016","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.neuropharm.2020.108236_bib92","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib200","unstructured":"Oksana A. Lenina, Irina V. Zueva, Vladimir V. Zobov, Vyacheslav E. Semenov, Patrick Masson, Konstantin A. Petrov. (submitted). Slow-binding reversible inhibitor of acetylcholinesterase with long-lasting action for prophylaxis of organophosphate poisoning."},{"key":"10.1016\/j.neuropharm.2020.108236_bib93","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.mcn.2019.03.001","article-title":"Small molecules as therapeutic drugs for Alzheimer's disease","volume":"96","author":"Oliver","year":"2019","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib94","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0167-4838(97)00133-7","article-title":"Long chain analogs of physostigmine as potential drugs for Alzheimer's disease: new insights into the mechanism of action in the inhibition of acetylcholinesterase","volume":"1343","author":"Perola","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2020.108236_bib95","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.neuropharm.2017.12.034","article-title":"C-547, a 6-methyluracil derivative with long-lasting binding and rebinding on acetylcholinesterase: pharmacokinetic and pharmacodynamic studies","volume":"131","author":"Petrov","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108236_bib96","doi-asserted-by":"crossref","first-page":"11870","DOI":"10.1523\/JNEUROSCI.0329-14.2014","article-title":"Schwann cells sense and control acetylcholine spillover at the neuromuscular junction by \u03b17 nicotinic receptors and butyrylcholinesterase","volume":"34","author":"Petrov","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib97","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3389\/fphar.2018.00766","article-title":"Autoregulation of acetylcholine release and micro-pharmacodynamic mechanisms at neuromuscular junction: selective acetylcholinesterase inhibitors for therapy of myasthenic syndromes","volume":"9","author":"Petrov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib98","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1038\/ncomms8653","article-title":"Protein conformational plasticity and complex ligand-binding kinetics explored by atomistic simulations and Markov models","volume":"6","author":"Plattner","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2020.108236_bib99","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.bbapap.2006.07.008","article-title":"Mutant of Bungarus fasciatus acetylcholinesterase with low affinity and low hydrolase activity toward organophosphorus esters","volume":"1764","author":"Poyot","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2020.108236_bib100","doi-asserted-by":"crossref","first-page":"11233","DOI":"10.1016\/S0021-9258(19)78115-0","article-title":"Site of fasciculin interaction with acetylcholinesterase","volume":"269","author":"Radic","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib101","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nsb0197-57","article-title":"Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A","volume":"4","author":"Raves","year":"1997","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib102","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuroscience.2012.12.054","article-title":"Butyrylcholinesterase and the cholinergic system","volume":"234","author":"Reid","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108236_bib103","doi-asserted-by":"crossref","first-page":"5128","DOI":"10.1073\/pnas.90.11.5128","article-title":"An electrostatic mechanism for substrate guidance down the aromatic gorge of acetylcholinesterase","volume":"90","author":"Ripoll","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2020.108236_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22122098","article-title":"Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study","volume":"22","author":"Rosenberry","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2020.108236_bib105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cbi.2016.05.032","article-title":"Hopeahainol A binds reversibly at the acetylcholinesterase (AChE) peripheral site and inhibits enzyme activity with a novel higher order concentration dependence","volume":"259","author":"Rosenberry","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2020.108236_bib106","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/toxsci\/kfj094","article-title":"Concentration-dependent kinetics of acetylcholinesterase inhibition by the organophosphate paraoxon","volume":"90","author":"Rosenfeld","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108236_bib107","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0010-4655(95)00053-I","article-title":"The calculation of the potential of mean force using computer simulations","volume":"91","author":"Roux","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.neuropharm.2020.108236_bib108","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1021\/acs.jctc.8b00173","article-title":"Kinetics of huperzine A dissociation from acetylcholinesterase via multiple unbinding pathways","volume":"14","author":"Rydzewski","year":"2018","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.neuropharm.2020.108236_bib109","doi-asserted-by":"crossref","first-page":"698","DOI":"10.3109\/02713681003794076","article-title":"Lowering of IOP by echothiophate iodide in pseudophakic eyes with glaucoma","volume":"35","author":"Schmidt","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.neuropharm.2020.108236_bib110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ygcen.2015.05.017","article-title":"Pure human butyrylcholinesterase hydrolyzes octanoyl ghrelin to desacyl ghrelin","volume":"224","author":"Schopfer","year":"2015","journal-title":"Gen. Comp. Endocrinol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib111","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0167-4838(96)00118-5","article-title":"Slow-binding inhibition: the general case","volume":"1298","author":"Sculley","year":"1996","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib112","doi-asserted-by":"crossref","first-page":"111787","DOI":"10.1016\/j.ejmech.2019.111787","article-title":"6-Methyluracil derivatives as peripheral site ligand-hydroxamic acid conjugates: reactivation for paraoxon-inhibited acetylcholinesterase","volume":"185","author":"Semenov","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108236_bib113","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0167-4838(98)00125-3","article-title":"Inhibition of acetylcholinesterase by an alkylpyridinium polymer from the marine sponge, Reniera sarai","volume":"1387","author":"Sep\u010di\u0107","year":"1998","journal-title":"Biochim. Biophys. Acta Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib114","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.taap.2009.08.014","article-title":"An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon","volume":"241","author":"Shenouda","year":"2009","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib115","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.coph.2005.01.014","article-title":"Acetylcholinesterase: \u2018classical\u2019 and \u2018non-classical\u2019 functions and pharmacology","volume":"5","author":"Silman","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib116","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cbi.2008.05.035","article-title":"Acetylcholinesterase: how is structure related to function?","volume":"175","author":"Silman","year":"2008","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2020.108236_bib117","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0167-4838(91)90029-Y","article-title":"On the inhibition of cholinesterase by D-tubocurarine","volume":"1079","author":"Stojan","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2020.108236_bib118","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1126\/science.1678899","article-title":"Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein","volume":"253","author":"Sussman","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108236_bib119","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/0076-6879(95)49034-5","article-title":"Kinetics of slow and tight-binding inhibitors","volume":"249","author":"Szedlacsek","year":"1995","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.neuropharm.2020.108236_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24234410","article-title":"Future therapeutic perspectives into the Alzheimer's disease targeting the oxidative stress hypothesis","volume":"24","author":"Teixeira","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.neuropharm.2020.108236_bib121","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0161-813X(00)00015-2","article-title":"Effects of huperzine used as pre-treatment against soman-induced seizures","volume":"22","author":"Tonduli","year":"2001","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2020.108236_bib122","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1021\/acsinfecdis.9b00012","article-title":"Quantifying the interactions between biomolecules: guidelines for assay design and data analysis","volume":"5","author":"Tonge","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.neuropharm.2020.108236_bib123","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.1021\/bi8002023","article-title":"Residence time of receptor-ligand complexes and its effect on biological function","volume":"47","author":"Tummino","year":"2008","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuropharm.2020.108236_bib124","doi-asserted-by":"crossref","DOI":"10.1039\/C8MD00296G","article-title":"Link between a high kon for drug binding and a fast clinical action: to be or not to be?","author":"Vauquelin","year":"2018","journal-title":"MedChemComm"},{"key":"10.1016\/j.neuropharm.2020.108236_bib125","first-page":"4","article-title":"Supercomputer lomonosov-2: large scale, deep monitoring and fine analytics for the user community","volume":"6","author":"Voevodin","year":"2019","journal-title":"Supercomput. Front. Innovat."},{"key":"10.1016\/j.neuropharm.2020.108236_bib126","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.bbr.2015.09.003","article-title":"Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer's disease","volume":"296","author":"Wang","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108236_bib127","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cbi.2012.10.016","article-title":"A combination of [+] and [-]-Huperzine A improves protection against soman toxicity compared to [+]-Huperzine A in Guinea pigs","volume":"203","author":"Wang","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.neuropharm.2020.108236_bib128","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1073\/pnas.97.2.623","article-title":"Specific chemical and structural damage to proteins produced by synchrotron radiation","volume":"97","author":"Weik","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neuropharm.2020.108236_bib129","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1021\/ja971226d","article-title":"Molecular dynamics of acetylcholinesterase dimer complexed with tacrine","volume":"119","author":"Wlodek","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2020.108236_bib130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00131402-200412000-00002","article-title":"Treatment review and update for myasthenia gravis","volume":"6","author":"Wolfe","year":"2004","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.neuropharm.2020.108236_bib131","doi-asserted-by":"crossref","first-page":"11340","DOI":"10.1021\/ja029775t","article-title":"How does huperzine A enter and leave the binding gorge of acetylcholinesterase? Steered molecular dynamics simulations","volume":"125","author":"Xu","year":"2003","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.neuropharm.2020.108236_bib132","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.neuint.2010.09.011","article-title":"Alpha-Tocopherol quinone inhibits beta-amyloid aggregation and cytotoxicity, disaggregates preformed fibrils and decreases the production of reactive oxygen species, NO and inflammatory cytokines","volume":"57","author":"Yang","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2020.108236_bib133","doi-asserted-by":"crossref","first-page":"22322","DOI":"10.1038\/srep22322","article-title":"Unexpected Reaction Pathway for butyrylcholinesterase-catalyzed inactivation of \"hunger hormone\" ghrelin","volume":"6","author":"Yao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2020.108236_bib134","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.4028\/www.scientific.net\/KEM.645-646.1374","article-title":"Pretreatment with huperzine A-loaded poly(lactide-co-glycolide) nanoparticles protects against lethal effects of soman-induced in mice","volume":"645\u2013646","author":"Zhang","year":"2015","journal-title":"Key Eng. Mater."},{"key":"10.1016\/j.neuropharm.2020.108236_bib135","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/0006-2952(86)90453-3","article-title":"Multiple binding of D-tubocurarine to acetylcholinesterase","volume":"35","author":"Zorko","year":"1986","journal-title":"Biochem. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082030304X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839082030304X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:07:00Z","timestamp":1758438420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839082030304X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":136,"alternative-id":["S002839082030304X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108236","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Slow-binding inhibitors of acetylcholinesterase of medical interest","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108236","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108236"}}